Moderna, Inc. (MRNA)
NASDAQ: MRNA · Real-Time Price · USD
46.49
-1.24 (-2.60%)
Jun 10, 2026, 11:54 AM EDT - Market open
Moderna Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 1,908 | 2,595 | 1,927 | 2,907 | 3,205 | 6,848 |
Short-Term Investments | 3,297 | 3,204 | 5,098 | 5,697 | 6,697 | 3,879 |
Cash & Short-Term Investments | 5,205 | 5,799 | 7,025 | 8,604 | 9,902 | 10,727 |
Cash Growth | -12.89% | -17.45% | -18.35% | -13.11% | -7.69% | 132.79% |
Accounts Receivable | 71 | 184 | 358 | 892 | 1,385 | 3,175 |
Inventory | 146 | 153 | 117 | 202 | 949 | 1,441 |
Other Current Assets | 348 | 408 | 599 | 627 | 1,195 | 728 |
Total Current Assets | 5,770 | 6,544 | 8,099 | 10,325 | 13,431 | 16,071 |
Net Property, Plant & Equipment | 2,792 | 2,853 | 2,955 | 2,658 | 2,139 | 1,383 |
Long-Term Investments | 2,251 | 2,336 | 2,494 | 4,677 | 8,318 | 6,843 |
Other Long-Term Assets | 675 | 605 | 594 | 766 | 1,970 | 372 |
Total Assets | 11,488 | 12,338 | 14,142 | 18,426 | 25,858 | 24,669 |
Accounts Payable | 161 | 317 | 405 | 520 | 487 | 302 |
Accrued Expenses | 1,912 | 1,386 | 1,427 | 1,798 | 2,101 | 1,472 |
Unearned Revenue | 102 | 99 | 153 | 568 | 2,038 | 6,253 |
Other Current Liabilities | 220 | 185 | 221 | 129 | 297 | 1,101 |
Total Current Liabilities | 2,395 | 1,987 | 2,206 | 3,015 | 4,923 | 9,128 |
Long-Term Debt | 590 | 590 | - | - | - | - |
Long-Term Leases | 658 | 673 | 710 | 1,218 | 1,004 | 705 |
Other Long-Term Liabilities | 437 | 438 | 325 | 339 | 808 | 691 |
Total Long-Term Liabilities | 1,685 | 1,701 | 1,035 | 1,557 | 1,812 | 1,396 |
Total Liabilities | 4,080 | 3,688 | 3,241 | 4,572 | 6,735 | 10,524 |
Additional Paid-in Capital | 1,503 | 1,382 | 866 | 371 | 1,173 | 4,211 |
Accumulated Other Comprehensive Income | 25 | 45 | -10 | -123 | -370 | -24 |
Retained Earnings | 5,880 | 7,223 | 10,045 | 13,606 | 18,320 | 9,958 |
Shareholders' Equity | 7,408 | 8,650 | 10,901 | 13,854 | 19,123 | 14,145 |
Total Liabilities & Equity | 11,488 | 12,338 | 14,142 | 18,426 | 25,858 | 24,669 |
Total Debt | 1,248 | 1,263 | 710 | 1,218 | 1,004 | 705 |
Net Cash (Debt) | 3,957 | 4,536 | 6,315 | 7,386 | 8,898 | 10,022 |
Net Cash Growth | -12.77% | -28.17% | -14.50% | -16.99% | -11.21% | 127.72% |
Net Cash Per Share | 10.11 | 11.66 | 16.45 | 19.34 | 21.39 | 23.25 |
Book Value | 7,408 | 8,650 | 10,901 | 13,854 | 19,123 | 14,145 |
Book Value Per Share | 18.93 | 22.24 | 28.39 | 36.27 | 45.97 | 32.82 |
Tangible Book Value | 7,408 | 8,650 | 10,901 | 13,854 | 19,123 | 14,145 |
Tangible Book Value Per Share | 18.93 | 22.24 | 28.39 | 36.27 | 45.97 | 32.82 |